IXHL
Income statement / Annual
Last year (2024), Incannex Healthcare Limited's total revenue was $12.00 K,
and the percentage change from the previous year is not available.
In 2024, Incannex Healthcare Limited's net income was -$18.46 M.
See Incannex Healthcare Limited,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
| Operating Revenue |
$12.00 K |
$0.00 |
$540.17 K |
$1.42 M |
$417.45 K |
$825.33 K |
$749.19 K |
$216.77 K |
$68.30 K |
$0.00 |
| Cost of Revenue |
$0.00
|
$88.08 K
|
$4.38 K
|
$685.20 K
|
$310.80 K
|
$29.95 K
|
$387.89 K
|
$396.97 K
|
$48.92 K
|
$13.76 K
|
| Gross Profit |
$12.00 K
|
$0.00
|
$535.79 K
|
$739.07 K
|
$106.65 K
|
-$29.95 K
|
$361.30 K
|
-$180.00 K
|
$19.38 K
|
-$13.76 K
|
| Gross Profit Ratio |
1
|
0
|
0.99
|
0.52
|
0.26
|
-0.04
|
0.48
|
-0.83
|
0.28
|
0
|
| Research and Development Expenses |
$12.88 M
|
$41.66 M
|
$3.70 M
|
$3.57 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$16.83 M
|
$7.93 M
|
$5.11 M
|
$74.31 K
|
$1.23 M
|
$231.80 K
|
$573.43 K
|
$1.68 M
|
$383.57 K
|
$415.95 K
|
| Selling & Marketing Expenses |
$348.00 K
|
$84.00 K
|
$1.90 M
|
$3.27 M
|
$280.35 K
|
$66.56 K
|
$864.65 K
|
$423.04 K
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$17.07 M
|
$7.92 M
|
$4.66 M
|
$4.84 M
|
$1.35 M
|
$375.15 K
|
$2.58 M
|
$1.64 M
|
$377.83 K
|
$415.95 K
|
| Other Expenses |
$103.00 K
|
-$595.00 K
|
-$10.70 M
|
-$28.18 K
|
$1.45 M
|
$544.88 K
|
$40.13 K
|
$13.82 M
|
$193.65 K
|
$1.50 M
|
| Operating Expenses |
$30.05 M
|
$13.64 M
|
$8.37 M
|
$8.40 M
|
$2.81 M
|
$2.37 M
|
$2.58 M
|
$15.92 M
|
$509.60 K
|
$1.92 M
|
| Cost And Expenses |
$30.05 M
|
$49.67 M
|
$8.38 M
|
$9.09 M
|
$3.12 M
|
$891.96 K
|
$2.97 M
|
$2.24 M
|
$558.53 K
|
$1.92 M
|
| Interest Income |
$206.00 K
|
$244.01 K
|
$4.31 K
|
$2.01 K
|
$3.12 K
|
$1.14 K
|
$2.36 K
|
$6.53 K
|
$424.25
|
$3.18 K
|
| Interest Expense |
$0.00
|
$3.01 K
|
$0.00
|
$0.00
|
$0.00
|
$59.57 K
|
$9.98 K
|
$38.27 K
|
$89.76
|
$91.94 K
|
| Depreciation & Amortization |
$103.00 K
|
$23.00 K
|
$7.84 M
|
$7.64 M
|
$24.50 K
|
$29.33 K
|
$40.13 K
|
$23.27 K
|
$11.65 K
|
$13.76 K
|
| EBITDA |
-$18.50 M |
-$13.55 M |
-$11.38 M |
-$8.57 M |
-$2.59 M |
-$861.00 K |
-$2.22 M |
-$2.03 M |
-$490.22 K |
-$2.09 M |
| EBITDA Ratio |
-1542
|
0
|
-21.06
|
-6.03
|
-6.19
|
-1.04
|
-2.96
|
-9.35
|
-7.18
|
0
|
| Operating Income Ratio |
-2503.42
|
0
|
-18.82
|
-5.39
|
-6.47
|
-1.08
|
-2.96
|
-9.35
|
-7.18
|
0
|
| Total Other Income/Expenses Net |
$11.61 M
|
$857.00 K
|
-$2.45 M
|
-$863.00 K
|
-$12.42 K
|
-$57.17 K
|
$4.96 K
|
-$14.11 M
|
-$59.59 K
|
-$1.70 M
|
| Income Before Tax |
-$18.43 M
|
-$48.81 M
|
-$10.29 M
|
-$8.53 M
|
-$2.71 M
|
-$1.00 M
|
-$2.38 M
|
-$16.14 M
|
-$549.82 K
|
-$2.20 M
|
| Income Before Tax Ratio |
-1535.75
|
0
|
-19.05
|
-5.99
|
-6.5
|
-1.21
|
-3.17
|
-74.44
|
-8.05
|
0
|
| Income Tax Expense |
$30.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$106.00 K
|
-$204.00 K
|
-$230.00 K
|
-$68.73 K
|
-$88.06 K
|
| Net Income |
-$18.46 M
|
-$48.81 M
|
-$10.29 M
|
-$8.53 M
|
-$3.24 M
|
-$1.91 M
|
-$2.18 M
|
-$15.90 M
|
-$549.82 K
|
-$2.11 M
|
| Net Income Ratio |
-1538.25
|
0
|
-19.05
|
-5.99
|
-7.77
|
-2.31
|
-2.91
|
-73.36
|
-8.05
|
0
|
| EPS |
-1.14 |
-3.17 |
-0.0346 |
-0.0349 |
-0.0159 |
-0.009 |
-0.0383 |
-0.5 |
-0.035 |
-0.17 |
| EPS Diluted |
-1.14 |
-3.17 |
-0.0346 |
-0.0349 |
-0.0159 |
-0.009 |
-0.0383 |
-0.5 |
-0.035 |
-0.17 |
| Weighted Average Shares Out |
$16.16 M
|
$15.39 M
|
$297.79 M
|
$244.50 M
|
$171.01 M
|
$111.86 M
|
$57.00 M
|
$31.91 M
|
$15.69 M
|
$12.11 M
|
| Weighted Average Shares Out Diluted |
$16.16 M
|
$15.39 M
|
$297.79 M
|
$244.50 M
|
$171.01 M
|
$111.86 M
|
$57.00 M
|
$31.91 M
|
$15.69 M
|
$12.11 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
